Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Oliver O'Sullivan et al.
Summary: This study describes the development of a remote COVID-19 rehabilitation assessment tool and highlights the significant rehabilitation needs of patients with post-COVID-19 syndrome. The study suggests that rehabilitation assessment should be offered to all patients experiencing post-COVID-19 symptoms, regardless of laboratory confirmation or initial disease severity.
BMJ MILITARY HEALTH
(2023)
Article
Immunology
Jessica Seessle et al.
Summary: Long COVID, defined as persistent symptoms after SARS-CoV-2 infection, can last for at least 1 year and significantly impact life quality. Neurocognitive symptoms, possibly related to autoimmunity indicated by elevated ANA titers, are more common in females and can persist even when SARS-CoV-2 antibody levels are not significantly different from patients without symptoms.
CLINICAL INFECTIOUS DISEASES
(2022)
Article
Medicine, General & Internal
Aylin Tanriverdi et al.
Summary: Extrapulmonary features are adversely affected in a substantial proportion of post-COVID-19 patients who recovered from mild and moderate disease severity in the mid-term. Comprehensive assessment and appropriate intervention strategies should be considered for non-severe post-COVID-19 patients.
IRISH JOURNAL OF MEDICAL SCIENCE
(2022)
Article
Public, Environmental & Occupational Health
Yeen Huang et al.
Summary: During the COVID-19 outbreak, younger people, healthcare workers, and individuals who spent excessive time thinking about the outbreak were identified as high-risk groups for psychological impact. Continual monitoring of psychological consequences for these populations should be a routine part of targeted interventions during crises.
PSYCHOLOGY HEALTH & MEDICINE
(2021)
Article
Virology
Stephen J. Halpin et al.
Summary: This study is the first report from the United Kingdom on post-discharge symptoms in COVID-19 survivors, identifying fatigue, breathlessness, and psychological distress as common symptoms that require planning of rehabilitation services for appropriate management.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Article
Multidisciplinary Sciences
Jiawen Deng et al.
Summary: Evidence from previous coronavirus outbreaks indicates that COVID-19 patients are at risk of developing psychiatric disorders such as depression, anxiety, and sleep disturbances. A systematic review and meta-analysis found high prevalence rates of depression (45%), anxiety (47%), and sleep disturbances (34%) in COVID-19 patients. Prevalence estimates varied based on screening tools used, highlighting the need for more studies on mental well-being in COVID-19 patients.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
(2021)
Review
Psychiatry
Maria de los Angeles Robinson-Agramonte et al.
Summary: There is a variable expression of clinical neurological manifestations in patients with COVID-19, including symptoms like fatigue, dizziness, impaired consciousness, ageusia, anosmia, radicular pain, and headache. Neuropsychiatric disorders associated with COVID-19 show exacerbation with symptoms such as depression, anxiety, mood alterations, psychosis, post-traumatic stress disorder, delirium, and cognitive impairment. The involvement of the immune system in the pathological mechanism of COVID-19 and its impact on mental health disorders is suggested.
WORLD JOURNAL OF PSYCHIATRY
(2021)
Article
Virology
Daniele Tomasoni et al.
Summary: A study found that 30% of COVID-19 recovered patients displayed pathological anxiety or depression, and 52.4% showed persistent symptoms. Pathological patients with HADS-A/D were more likely to report symptom persistence even after adjusting for age, gender, and disease severity. Therefore, psychological assessments should be encouraged in follow-up of COVID-19 patients.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Review
Immunology
Thor Mertz Schou et al.
Summary: COVID-19 patients may exhibit psychiatric symptoms such as anxiety, depression, PTSD, cognitive deficits, fatigue, and sleep disturbances. Potential risk factors include disease severity, duration of symptoms, and female sex. Survivors of COVID-19 are at risk of psychiatric sequelae, but symptoms generally improve over time.
BRAIN BEHAVIOR AND IMMUNITY
(2021)
Article
Medicine, General & Internal
Chaolin Huang et al.
Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.
Article
Medicine, General & Internal
Mattia Bellan et al.
Summary: The study examined the prevalence of lung function, exercise function, and psychological sequelae among survivors of severe COVID-19 four months after discharge. Over half of patients experienced reduced lung capacity, one-fifth had functional impairment, and about one-fifth showed symptoms of posttraumatic stress. These findings suggest that a significant proportion of COVID-19 survivors may continue to experience respiratory, functional, or psychological issues months after hospital discharge.
Letter
Psychiatry
Cesar Fernandez-de-las-Penas et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH
(2021)
Article
Immunology
Mazza Mario Gennaro et al.
Summary: The mental health implications and cognitive status of COVID-19 pneumonia survivors were prospectively evaluated one and three months after hospital discharge. 35.8% of patients still self-rated symptoms in the clinical range in at least one psychopathological dimension at three months post-discharge. Baseline systemic immune-inflammation index predicted self-rated depressive symptomatology and cognitive impairment at three-months follow-up.
BRAIN BEHAVIOR AND IMMUNITY
(2021)
Article
Respiratory System
Dominic L. Sykes et al.
Summary: Recent studies have shown that COVID-19 patients may experience lasting symptoms, with females being more likely to report residual symptoms. The phenomenon of Long-COVID may not be solely attributed to the impact of SARS-CoV-2, indicating a potential role of biopsychosocial effects of COVID-19 in its etiology.
Article
Multidisciplinary Sciences
Federica Alemanno et al.
Summary: Neurological, psychiatric, and psychological impairments are common complications of COVID-19. A study on the cognitive functions of patients in the sub-acute phase of the disease found that 80% of patients had neuropsychological deficits and 40% showed signs of mild-to-moderate depression. Cognitive impairments were correlated with patients' age, and a significant percentage of patients showed signs of post-traumatic stress disorder one month after discharge.
Article
Medicine, General & Internal
Maxime Taquet et al.
Summary: This study investigated the incidence and co-occurrence of long-COVID features in COVID-19 survivors, with comparisons to influenza patients, using electronic health records data. The findings showed that long-COVID clinical features were more commonly reported after COVID-19 infection, and differences were associated with sex, age, and illness severity.
Letter
Respiratory System
Sindhu B. Naidu et al.
EUROPEAN RESPIRATORY JOURNAL
(2021)
Article
Medicine, General & Internal
Y. F. Shang et al.
Summary: This study analyzed the sequelae of COVID-19 in 1174 recovered patients, finding that 55.4% experienced some form of sequelae, with fatigue, sleep disorders, and shortness of breath being the most common symptoms.
JOURNAL OF INTERNAL MEDICINE
(2021)
Article
Psychiatry
Sandeep Grover et al.
Summary: The study evaluated psychological morbidity, PTSD, fatigue, and perceived stigma among patients with COVID-19 after recovery. Results showed a significant proportion of patients experiencing these issues, especially PTSD and fatigue.
ASIAN JOURNAL OF PSYCHIATRY
(2021)
Article
Medicine, General & Internal
Alvaro Romero-Duarte et al.
Summary: Long-term effects of COVID-19, also known as Long COVID, affect over 10% of patients, with severe cases presenting a higher frequency of sequelae. This study aimed to identify and quantify the frequency and outcomes associated with sequelae or persistent symptomatology (SPS) in patients during the 6 months after discharge for COVID-19. The study found that most surviving patients experienced various types of sequelae, with respiratory, systemic, neurological, and mental health sequelae being the most common.
Article
Neurosciences
Cesar Fernandez-de-las-Penas et al.
Summary: This study investigated the association between pre-existing migraine and post-COVID symptoms in patients recovering from COVID-19, finding that patients with a history of migraine were more likely to experience post-COVID symptoms, particularly fatigue, but no difference was observed in the prevalence of headache symptoms. This suggests that the pathophysiological changes associated with migraine may predispose individuals to the development of post-COVID symptoms.
FRONTIERS IN HUMAN NEUROSCIENCE
(2021)
Article
Clinical Neurology
Jennifer A. Frontera et al.
Summary: Long-term outcomes of COVID-19 hospitalized patients, particularly those with neurological complications, showed impairments in daily living activities, cognition, anxiety, depression, and sleep. Patients with neurological complications had significantly worse functional outcomes compared to those without.
JOURNAL OF THE NEUROLOGICAL SCIENCES
(2021)
Article
Multidisciplinary Sciences
Dominik Menges et al.
Summary: This study found a significant proportion of individuals experiencing longer-term consequences after SARS-CoV-2 infection. Some patients did not fully recover six to eight months post-diagnosis, with many experiencing symptoms of fatigue, dyspnea, or depression. Additionally, a high percentage sought healthcare services after acute illness, but some individuals did not seek further care despite ongoing symptoms.
Article
Medicine, General & Internal
Lovisa Hellgren et al.
Summary: A study in Sweden investigated the long-term effects of COVID-19 on brain MRI and neurocognitive function in high-risk patients, finding that most patients had abnormal MRI findings or impaired neurocognitive function, along with reported fatigue.
Article
Medicine, General & Internal
Farnaz Zahoor et al.
Summary: This study followed healthcare workers who survived COVID-19 infection for six months post-recovery and found no increased risk of anxiety or depression compared to uninfected healthcare workers. It is recommended to conduct longitudinal studies with larger sample sizes and longer follow-up periods.
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
(2021)
Article
Psychiatry
Rafal Dankowski et al.
Summary: This study evaluated the presence of anxiety and depressive symptoms in patients who recently recovered from COVID-19, with more pronounced intensity in women and mild depressive symptoms observed in nearly 30% of patients.
NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA
(2021)
Letter
Clinical Neurology
Jun Shigemura et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES
(2020)
Review
Immunology
Nina Vindegaard et al.
BRAIN BEHAVIOR AND IMMUNITY
(2020)
Article
Multidisciplinary Sciences
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH
(2020)
